Highlights:
• Live prototype dashboard demonstration
• Discussion on usability and interpretation
• Stakeholder feedback to refine the platform
#AMR #PrIMAVeRa #PublicHealth #Ecraid #ISCIII
@europevaccine.bsky.social @umcutrecht.bsky.social @ihieurope.bsky.social
We invite policymakers, vaccine developers, public health professionals, and researchers to help shape a decision-support platform for prioritising vaccines and monoclonal antibodies to mitigate AMR.
Last Call to register!
🔔 Join the PrIMAVeRa Stakeholder Meeting & Live hashtag#AMR Dashboard Demo in Munich!
📅 Sunday, 19 April 2026
🕛 12:00 – 15:00 (CEST)
📍 H4 Hotel München Messe (5 mins’ walk from ESCMID venue)
Limited spots available! 📩 Interested? Send an email to events@ecraid.eu.
@infectiousdz.bsky.social @idsky.bsky.social
Ecraid has joined the BEAM Alliance, reinforcing our commitment to tackling antimicrobial resistance. By contributing our clinical research expertise and network, we aim to better connect innovation with real-world needs & help shape future AMR solutions in Europe.
👉🏽Read more: bit.ly/BeamAlliance
📣 Arjan van Manen joins us as Head of Business Development.
With 20+ years in clinical strategy, he’s focused on closing the gap between clinical need & investment risk.
🤝🏽 Understanding challenges to deliver data-driven, tailored solutions.
📍At ESCMID? Connect with him!
🔗https://bit.ly/ArjanEcraid
This survey is organised by the EU-funded CoMeCT project and the University of Verona. @ec.europa.eu @scienceinnovation.ec.europa.eu @erc.europa.eu
@horizoneu.bsky.social @ecrin.bsky.social #ClinicalResearch #pandemicpreparedness
📝 Have insights on ethical review procedures for cohort studies? Participate in this survey (15–20 min) to help improve the efficiency of ethical review processes for cohort studies during public health emergencies.
www.id-care.net/post/share-y...
@infectiousdz.bsky.social @scievents.bsky.social @idsky.bsky.social @medsky.social
📣 Our March newsletter is out!
🔬 Join us at #ESCMIDGlobal2026 in Munich (Booth F21)
🎓 5th Young Investigator Workshop – 19 April, 09:30 CEST
🏥 ECRAID-Prime trial advances patient-centric research
Plus new publications & collaborations.
👉🏽Subscribe now: mailchi.mp/ecraid/newsl...
Join the Young Investigator Workshop at #ESCMIDGlobal 2026 for practical insights and science you can actually use!
Early-career investigators are driven to deliver meaningful research, but navigating the “how” isn’t always straightforward.
📍 Room 2 (ICM Ground Floor)
👉 bit.ly/4uKdN0r
Looking ahead to #ESCMIDGlobal 2026 in Munich, we’re reflecting on the energy & collaboration from Vienna last year. Great to connect with so many experts & partners advancing ID research. Excited to continue these conversations in Munich.
Will you be there? Visit us at booth F21: bit.ly/474r0qy
@ec.europa.eu @vcstx.bsky.social
📢Ecraid has joined the WHO Global Clinical Trials Forum.
This milestone boosts our mission to advance high-quality research, strengthen global collaboration, and improve trial readiness, data sharing, and patient outcomes worldwide.
Read more: bit.ly/418YDEh
#GlobalHealth @whowpro.bsky.social
A recent article published in Contemporary Clinical Trial Communications evaluates the considerations raised during the regulatory & ethics review of five ID #PlatformTrials: #ECRAIDPrime, #RECLAIM, #REMAPCAP, #RECOVERY, and #SNAP.
Explore the full article here bit.ly/4v0qSCH
#TrialInnovation
@infectiousdz.bsky.social @scievents.bsky.social @escmid.bsky.social
📍Visit us at booth #F21 at #ESCMID Global 2026 in Munich!
Innovation in ID requires strong partnerships.
🔬At Ecraid we're committed to building & growing collaborations across Europe to strengthen clinical research & tackle AMR.
Meet our team & explore how we can work together: bit.ly/474r0qy
Two new #ECRAIDBase publications available!
🫁 The first provides a detailed narrative of the POS-VAP study.
📊 The second asks how do we measure knowledge, attitudes, & practices around biomedical data reuse?
Explore the papers bit.ly/4beBA0z
#ClinicalTrials #VAP #DataScience #CriticalCare
@infectiousdz.bsky.social @scievents.bsky.social @escmid.bsky.social
Will you be at #ESCMIDGlobal 2026 in Munich? Visit Ecraid at booth F21.
As AMR and emerging infections continue to challenge healthcare systems, collaboration across academia, clinical networks & industry is essential.
Interested in connecting? Book a meeting: bit.ly/474r0qy
#InfectiousDiseases
The world of #ClinicalResearch is evolving fast - are you ready to grow with it?
Join our 5th Young Investigator Workshop at #ESCMIDGlobal2026. A dedicated space for early-career researchers to gain practical, real-world insights you won't find in textbooks: bit.ly/4uKdN0r
@escmid.bsky.social
@lenniederde.bsky.social @scievents.bsky.social @infectiousdz.bsky.social #AntimicrobialResistance #ClinicalResearch #DrugDiscovery #Innovation #PublicHealth #Partnership
At the AMR Conference in Basel, Ecraid announced a new partnership with @incate.bsky.social. Together we’re connecting clinical research & translational innovation to accelerate antimicrobial development & strengthen the pipeline against #AMR. Read how we combine our strengths: bit.ly/INCATE-Ecraid
@ec.europa.eu @scienceinnovation.ec.europa.eu
@erc.europa.eu @vcstx.bsky.social @horizoneu.bsky.social @oxprimarycare.bsky.social @ecrin.bsky.social @lenniederde.bsky.social #horizon2020 #horizoneurope
#respiratoryillness #Flu #ClinicalResearch #pandemicpreparedness
Read more about the EU-funded adaptive platform trials in primary care, and perpetual ongoing studies here:
🦠 ECRAID-Prime Adaptive Platform Trial www.ecraid.eu/ecraid-prime...
🔬ECRAID-Base POS - www.ecraid.eu/ecraid-base/...
Last Friday, @christophercbutler.bsky.social presented at the #RethinkingClinicalTrials webinar (hosted by @dcrinews.bsky.social and @pctcollaboratory.bsky.social). He highlighted pre-pandemic studies & how ECRAID-Prime & ECRAID-Base are strengthening #Europe’s response to future health threats.
@ec.europa.eu @ihieurope.bsky.social @lenniederde.bsky.social
Explore our Perpetual Observational Studies and how their real-world data generated can help advance clinical research and outbreak preparedness. www.ecraid.eu/ecraid-base/...
🫱🏼🫲🏻 We're proud to present the #PrIMAVeRaProject and our #perpetualobervationalstudies at the 7th @amr-accelerator.bsky.social Cross-Project Meeting held in Basel yesterday. We look forward to seeing everyone again at the PrIMAVeRa stakeholder meeting at #ESCMID2026!
@elskesieswerda.bsky.social
@scienceinnovation.ec.europa.eu
